“…pancreatic and colon cancer (Baek et al, 2004;Lim et al, 2006;Kürbitz et al, 2011;Cordero-Herrera et al, 2013) (Sukhthankar et al, 2010;Kuerbitz et al, 2011;Wang et al, 2011b;Lee et al, 2012;Luo et al, 2014;Fu et al, 2019) attenuating angiogenesis MPI, ACTA1, PECAM1 lung cancer (Deng et al, 2019) inhibiting metastasis CDH1/2, CSRC, ERBB2, ESR2, MAPK8, MIR138, NFKB, PTK2, SLC22A5, SNAIL1/2, TJP1, VIM, lung, colon, breast, bladder, and prostate cancer (Shimizu et al, 2005a;Punathil et al, 2008;Sen et al, 2010;Sen and Chatterjee, 2011;Deng and Lin, 2011;Ko et al, 2013;Mukherjee et al, 2014;Li et al, 2015;Huang et al, 2016b;Luo et al, 2017) promoting apoptosis and autophagy AKT1, AP1, APAF1, ATM, BAD, BAX, BCL2/L1, BIRC5, CASP2/3/8/9, CCNB1, CDC2, CDKN1A, CYC, DIABLO, EGFR, ERBB2/3, FAS, FASLG, GDF15, JNK1/2, KRAS, MAPK1/14, MLH1, MSH2, MTCO2, MYC, NFKB, PARP1, PEG2, PGE2, PIK3CA, PRKAA2, PTEN, PTK2, SP1, TP53 pancreatic, lung, colon, head and neck, breast, and bladder cancer (Shimizu et al, 2005b;Park et al, 2009;Deng and Lin, 2011;Kang et al, 2013;Cerezo-Guisado et al, 2015;Li et al, 2016;Luo et al, 2017;Huang et al, 2017;Ni et al, 2018;Gu et al, 2018;Wei et al, 2018;Lu et al, 2019) sensitizing chemotherapy ABCG2/B1, ATP7A/B, BAX, BBC3, CASP3/7/9, CDKN...…”